James Wymer

ORCID: 0000-0003-0809-2977
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Amyotrophic Lateral Sclerosis Research
  • Neurogenetic and Muscular Disorders Research
  • Dysphagia Assessment and Management
  • Parkinson's Disease Mechanisms and Treatments
  • Pain Mechanisms and Treatments
  • Herpesvirus Infections and Treatments
  • Genetic Neurodegenerative Diseases
  • Botulinum Toxin and Related Neurological Disorders
  • Insect and Pesticide Research
  • Child Nutrition and Feeding Issues
  • Cholinesterase and Neurodegenerative Diseases
  • Tracheal and airway disorders
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • Virus-based gene therapy research
  • Neurological diseases and metabolism
  • Advancements in Transdermal Drug Delivery
  • Toxoplasma gondii Research Studies
  • Neurobiology and Insect Physiology Research
  • Protist diversity and phylogeny
  • Neurological disorders and treatments
  • Biochemical Acid Research Studies
  • Pharmacological Receptor Mechanisms and Effects
  • Nerve injury and regeneration
  • Dialysis and Renal Disease Management
  • Prion Diseases and Protein Misfolding

University of Florida
2017-2025

Florida College
2017-2024

Google (United States)
2022-2023

Nova Southeastern University
2023

University of South Florida
2023

Liechtenstein Institute
2023

John Wiley & Sons (United States)
2023

Hudson Institute
2023

Newcastle upon Tyne Hospitals NHS Foundation Trust
2022

Newcastle University
2022

Abstract An orally administered, fixed‐dose coformulation of sodium phenylbutyrate‐taurursodiol (PB‐TURSO) significantly slowed functional decline in a randomized, placebo‐controlled, phase 2 trial ALS (CENTAUR). Herein we report results long‐term survival analysis participants CENTAUR. In CENTAUR, adults with were randomized 2:1 to PB‐TURSO or placebo. Participants completing the 6‐month (24‐week) eligible receive open‐label extension. all‐cause mortality (35‐month maximum follow‐up...

10.1002/mus.27091 article EN cc-by-nc Muscle & Nerve 2020-10-16

Keratinocytes are implicated in sensory transduction and can influence nociception, but whether these contribute to chronic pain is not known. In neurons, voltage-gated sodium channels (Na(v)) involved neuropathic activated by depolarization. Since keratinocytes also show changes membrane potential, we used RT-PCR, situ hybridization, immunohistochemistry investigate the expression of cells. Na(v)1.1, Na(v)1.6, Na(v)1.8 were localized within rat epidermis. addition, release ATP from response...

10.1016/j.pain.2008.03.016 article EN Pain 2008-04-29

Abstract Objective To evaluate the efficacy and safety of DM/Q (capsules containing dextromethorphan [DM] quinidine [Q]) compared with placebo, taken twice daily, for treatment pseudobulbar affect over a 12‐week period in multiple sclerosis patients. Methods A total 150 patients were randomized double‐blind, placebo‐controlled study to assess validated Center Neurologic Study‐Lability Scale. Each patient also recorded number episodes experienced between visits, estimated quality life...

10.1002/ana.20828 article EN Annals of Neurology 2006-04-21

The aims of this multicenter, randomized, placebo-controlled, double-blind trial were to confirm the efficacy lacosamide at a daily dose 400 mg/d and explore efficacy, safety, tolerability 200 600 in treatment painful diabetic neuropathy.The consisted 2-week run-in period, 6-week titration phase, 12-week maintenance during which patients received placebo or fixed doses 200, 400, mg/d. No back was allowed trial. primary criterion change Likert pain score from baseline average over last 4...

10.1097/ajp.0b013e318196d2b6 article EN Clinical Journal of Pain 2009-05-21

Summary In a variety of chronic pain conditions, calcitonin gene-related peptide (CGRP) is expressed at high levels in the skin, blood, and cerebrospinal fluid. Our results reveal that much increase may be due to CGRPβ isoform made by epidermal keratinocytes, which express CGRP immunoreactivity human animal conditions. Calcitonin vasodilatory has been detected fluid (CSF) under inflammatory presumably derived from peptidergic C Aδ innervation. Herein, immunolabeling (IL) was keratinocytes...

10.1016/j.pain.2011.04.033 article EN Pain 2011-06-19

ObjectiveTo determine if peripheral neuropathology exists among the innervation of cutaneous arterioles and arteriole–venule shunts (AVS) in fibromyalgia (FM) patients.

10.1111/pme.12139 article EN Pain Medicine 2013-05-20

The goal of this randomized, blinded, crossover clinical trial was to determine whether Nuedexta (dextromethorphan and quinidine) enhanced speech, swallowing, salivation in patients with ALS. Sixty amyotrophic lateral sclerosis (ALS) received either or placebo for 28 30 days, followed by a 10 15-day washout period. Subsequently, were switched the opposite treatment arm remaining days trial. primary endpoint reduction self-report Center Neurologic Study Bulbar Function Scale (CNS-BFS) score....

10.1007/s13311-016-0508-5 article EN cc-by Neurotherapeutics 2017-01-09

<h3>Importance</h3> Understanding the natural history of familial amyotrophic lateral sclerosis (ALS) caused by <i>SOD1</i> mutations (ALS<sup>SOD1</sup>) will provide key information for optimising clinical trials in this patient population. <h3>Objective</h3> To establish an updated ALS<sup>SOD1</sup>. <h3>Design, setting and participants</h3> Retrospective cohort study from 15 medical centres North America evaluated records 175 patients with ALS genetically confirmed mutations, cared...

10.1136/jnnp-2016-313521 article EN Journal of Neurology Neurosurgery & Psychiatry 2016-06-03

The versatility of somatosensation arises from heterogeneous dorsal root ganglion (DRG) neurons. However, soma transcriptomes individual human DRG (hDRG) neurons-critical in-formation to decipher their functions-are lacking due technical difficulties. Here, we developed a novel approach isolate hDRG neuron somas for deep RNA sequencing (RNA-seq). On average, >9,000 unique genes per were detected, and 16 neuronal types identified. Cross-species analyses revealed remarkable divergence among...

10.1101/2023.03.17.533207 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2023-03-18

Abstract The versatility of somatosensation arises from heterogeneous dorsal root ganglion (DRG) neurons. However, soma transcriptomes individual human (h)DRG neurons—critical information to decipher their functions—are lacking due technical difficulties. In this study, we isolated somata hDRG neurons and conducted deep RNA sequencing (RNA-seq) detect, on average, over 9,000 unique genes per neuron, identified 16 neuronal types. These results were corroborated validated by spatial...

10.1038/s41593-024-01794-1 article EN cc-by Nature Neuroscience 2024-11-04

The large subunit of the herpes simplex virus type 2 (HSV-2) ribonucleotide reductase (RR1) is demonstrated to possess serine/threonine-specific kinase activity. Computer-assisted sequence analysis identified regions within amino terminus ICP10 that are homologous catalytic domain known protein kinases (PKs). An in vitro assay confirmed ability ICP10, immunoprecipitated from either HSV-2-infected cells or transfected with an expression vector, autophosphorylate and transphosphorylate...

10.1128/jvi.63.8.3389-3398.1989 article EN Journal of Virology 1989-08-01

Objective: Speech and swallowing impairments are highly prevalent in individuals with amyotrophic lateral sclerosis (ALS) contribute to reduced quality of life, malnutrition, aspiration, pneumonia death. Established practice parameters for bulbar dysfunction ALS do not currently exist. The aim this study was identify current patterns the evaluation speech function within participating Northeast clinics United States. Methods results: A 15-item survey emailed all registered NEALS centres....

10.1080/21678421.2017.1313868 article EN Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2017-04-20

Universally established comprehensive clinical bulbar scales objectively assessing disease progression in amyotrophic lateral sclerosis (ALS) are currently lacking. The goal of this working group project is to design a best practice set provisional ALS guidelines, available for immediate implementation within all clinics.ALS specialists across multiple related disciplines participated series symposia, intending identify and summarize the accepted practices assessment management dysfunction...

10.1002/mus.26408 article EN Muscle & Nerve 2019-01-09

Objective To evaluate safety, dose response, and preliminary efficacy of reldesemtiv over 12 weeks in patients with amyotrophic lateral sclerosis (ALS). Methods: Patients (≤2 years since diagnosis) slow upright vital capacity (SVC) ≥60% were randomized 1:1:1:1 to 150, 300, or 450 mg twice daily (bid) placebo; active treatment was 4-week follow-up. Primary endpoint change percent predicted SVC at weeks; secondary measures included ALS Functional Rating Scale-Revised (ALSFRS-R) muscle strength...

10.1080/21678421.2020.1822410 article EN cc-by-nc-nd Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2020-09-24

<h3>Background and Objective</h3> The objective of this study was to evaluate the short-term physiologic effect one-year functional a 12-week inspiratory expiratory respiratory strength training (RST) program in individuals with amyotrophic lateral sclerosis (ALS). <h3>Methods</h3> A double-blinded, randomized, sham-controlled trial conducted 45 early-stage ALS. Participants were randomized into 12 weeks active RST (30% load, n = 23) or sham (0% 22). An intent-to-treat analysis conducted....

10.1212/wnl.0000000000206830 article EN Neurology 2023-02-20
Sabrina Paganoni Christina N. Fournier Eric A. Macklin Lori B. Chibnik Melanie Quintana and 95 more Benjamin R. Saville Michelle A. Detry Matteo Vestrucci Joe Marion Anna McGlothlin Senda Ajroud‐Driss Marianne Chase Lindsay Pothier Brittney Harkey Hong Yu Alexander Sherman Jeremy M. Shefner Meghan Hall Gale Kittle James Berry Suma Babu Jinsy Andrews Derek D’Agostino Eric Tustison Elisa Giacomelli Erica Scirocco Gustavo Alameda Eduardo Locatelli Doreen Ho Adam Quick Jonathan Katz Daragh Heitzman Stanley H. Appel Sheetal Shroff Kevin J. Felice Nicholas J. Maragakis Zachary Simmons Timothy M. Miller Nicholas Olney Michael D. Weiss Stephen A. Goutman Joseph Americo Fernandes Omar Jawdat Margaret Owegi Laura A. Foster Tuan Vu Hristelina Ilieva Daniel S. Newman Ximena Arcila-Londono Carlayne E. Jackson Shafeeq Ladha Terry Heiman‐Patterson James B. Caress Andrea Swenson Amanda Peltier Richard A. Lewis Dominic Fee Matthew Elliott Richard Bedlack Edward J. Kasarskis Lauren Elman Jeffrey Rosenfeld David Walk Courtney McIlduff Paul Twydell Eufrosina Young Kristin Johnson Kourosh Rezania Namita Goyal Jeffrey A. Cohen Michael Benatar Vovanti Jones Jonathan D. Glass Jaimin Shah Said R. Beydoun James Wymer Lindsay Zilliox Shakti Nayar Gary L. Pattee Jennifer M. Martinez‐Thompson Brittany Harvey Shital Patel Paul Mahoney Petra W. Duda Merit Cudkowicz Ivor S. Douglas Po-Ying Lai Rachel Donahue H.L. Chen Jianing Wang Nithya Mathai Gabriela Lopes Alexandra McCaffrey Jennifer Scalia Sarah Luppino Clotilde Lagier‐Tourenne Ghazaleh Sadri‐Vakili Stephen J. Kolb Sarah Heintzman Robert Sufit

Importance The etiology of amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disease, is unknown. However, neuroinflammation and complement activation may play role in disease progression. Objective To determine the effects zilucoplan, an inhibitor C5, individuals with ALS. Design, Setting, Participants Zilucoplan was tested as regimen A HEALEY ALS Platform Trial, phase 2 to 3 multicenter, randomized, double-blind, placebo-controlled perpetual platform clinical trial sharing...

10.1001/jamanetworkopen.2024.59058 article EN cc-by-nc-nd JAMA Network Open 2025-02-17

Regulation of the expression herpes simplex virus (HSV) type 2 large subunit ribonucleotide reductase (ICP10) gene was studied directly by immunofluorescence or chloramphenicol acetyltransferase analysis with hybrid ICP10 promoter constructions. In Vero cells, cotransfection DNA encoding HSV IE110 Vmw65 proteins HCMV IE2 enhanced at least 10-fold. contrast, minimally IE175 low doses and slightly reduced high doses. IE110-mediated trans-activation minimal in primary astrocytes cells from line...

10.1128/jvi.63.6.2773-2784.1989 article EN Journal of Virology 1989-06-01

<h3>Importance</h3> Cryptogenic sensory polyneuropathy (CSPN) is a common generalized slowly progressive neuropathy, second in prevalence only to diabetic neuropathy. Most patients with CSPN have significant pain. Many medications been tried for pain reduction CSPN, including antiepileptics, antidepressants, and sodium channel blockers. There are no comparative studies that identify the most effective medication CSPN. <h3>Objective</h3> To determine which (pregabalin, duloxetine,...

10.1001/jamaneurol.2020.2590 article EN JAMA Neurology 2020-08-17
Coming Soon ...